These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38020163)

  • 1.
    Dindi UMR; Sadiq SP; Al-Ghamdi S; Alrudian NA; Dayel SB; Abuderman AA; Shahid M; Ramesh T; Vilwanathan R
    Front Med (Lausanne); 2023; 10():1282820. PubMed ID: 38020163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative inhibition of sirtuin 6 by imidazole derivative triggers oxidative stress-mediated apoptosis associated with Nrf2/Keap1 signaling in non-small cell lung cancer cell lines.
    Dindi UMR; Al-Ghamdi S; Alrudian NA; Dayel SB; Abuderman AA; Saad Alqahtani M; Bahakim NO; Ramesh T; Vilwanathan R
    Front Pharmacol; 2023; 14():1335305. PubMed ID: 38235110
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site.
    Giordano D; Scafuri B; De Masi L; Capasso L; Maresca V; Altucci L; Nebbioso A; Facchiano A; Bontempo P
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaloids from psychotria target sirtuins: in silico and in vitro interaction studies.
    Sacconnay L; Ryckewaert L; Dos Santos Passos C; Guerra MC; Kato L; Alves de Oliveira CM; Henriques A; Carrupt PA; Simões-Pires C; Nurisso A
    Planta Med; 2015 Apr; 81(6):517-24. PubMed ID: 25469857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing Sirtuin 6 induces cell cycle arrest and apoptosis in non-small cell lung cancer cell lines.
    Krishnamoorthy V; Vilwanathan R
    Genomics; 2020 Sep; 112(5):3703-3712. PubMed ID: 32360514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective.
    Yoon YK; Oon CE
    Anticancer Agents Med Chem; 2016; 16(8):1003-1016. PubMed ID: 26961318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
    Trapp J; Jung M
    Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.
    Kruszewski M; Szumiel I
    DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells.
    Cea M; Soncini D; Fruscione F; Raffaghello L; Garuti A; Emionite L; Moran E; Magnone M; Zoppoli G; Reverberi D; Caffa I; Salis A; Cagnetta A; Bergamaschi M; Casciaro S; Pierri I; Damonte G; Ansaldi F; Gobbi M; Pistoia V; Ballestrero A; Patrone F; Bruzzone S; Nencioni A
    PLoS One; 2011; 6(7):e22739. PubMed ID: 21818379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of sirtuin inhibitors.
    Chen L
    Curr Med Chem; 2011; 18(13):1936-46. PubMed ID: 21517778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of sirtuin enzymes in cestodes and evaluation of sirtuin inhibitors as new cestocidal molecules.
    Vaca HR; Celentano AM; Toscanini MA; Hauser AT; Macchiaroli N; Cuestas ML; Nusblat AD; Sippl W; Elissondo MC; Jung M; Camicia F; Rosenzvit MC
    Int J Parasitol; 2022 Apr; 52(5):317-329. PubMed ID: 35150663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
    Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
    Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuins and disease: the road ahead.
    Carafa V; Nebbioso A; Altucci L
    Front Pharmacol; 2012; 3():4. PubMed ID: 22319497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based development of novel sirtuin inhibitors.
    Schlicker C; Boanca G; Lakshminarasimhan M; Steegborn C
    Aging (Albany NY); 2011 Sep; 3(9):852-72. PubMed ID: 21937767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures, substrates, and regulators of Mammalian sirtuins - opportunities and challenges for drug development.
    Moniot S; Weyand M; Steegborn C
    Front Pharmacol; 2012; 3():16. PubMed ID: 22363286
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
    Schemies J; Uciechowska U; Sippl W; Jung M
    Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.